Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics

被引:179
作者
Nagayama, Susumu [1 ]
Ogawara, Ken-ichi [1 ]
Fukuoka, Yoshiko [1 ]
Higaki, Kazutaka [1 ]
Kimura, Toshikiro [1 ]
机构
[1] Okayama Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Okayama 7008530, Japan
关键词
polystyrene nanosphere; receptor-mediated uptake; Opsonins; hepatic uptake; Kupffer cells; POLY(D; L-LACTIC ACID) NANOPARTICLES; PLASMA-PROTEIN ADSORPTION; POLYMERIC IGA RECEPTOR; IN-VIVO; GADOLINIUM CHLORIDE; BLOOD PROTEINS; RAT-LIVER; 2-DIMENSIONAL ELECTROPHORESIS; LIPOSOMES; SERUM;
D O I
10.1016/j.ijpharm.2007.04.036
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The relationship between the time-dependent change in serum proteins adsorbed on nanoparticles and their disposition to the liver was investigated by employing lecithin-coated polystyrene nanosphere with a size of 50 nm (LNS-50) as a model nanoparticle in rats. The total amount of proteins adsorbed on LNS-50 increased and the qualitative profile of serum proteins adsorbed on LNS-50 changed during the incubation with serum up to 360 min. The liver perfusion study indicated that the hepatic uptake of LNS-50 incubated with serum for 360 min was significantly larger than those of LNS-50 incubated for shorter period. It was suggested that the increase in the hepatic uptake of LNS-50 with the increase in incubation time would be ascribed mainly to the increase in the opsonin-mediated uptake by Kupffer cells. Semi-quantification of major opsonins, complement C3 (C3) and immunoglobulin G (IgG), and in vitro uptake study in primary cultured Kupffer cells demonstrated that the increase in C3 and IgG amounts adsorbed on LNS-50 was directly reflected in the increased disposition of LNS-50 to Kupffer cells. These results indicate that the amounts of opsonins associated on nanoparticles would change over time and this process would be substantially reflected in the alteration of their hepatic disposition characteristics. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:215 / 221
页数:7
相关论文
共 43 条
[1]  
Absolom D R, 1986, Methods Enzymol, V132, P281
[2]  
Allemann E, 1997, J BIOMED MATER RES, V37, P229, DOI 10.1002/(SICI)1097-4636(199711)37:2<229::AID-JBM12>3.0.CO
[3]  
2-9
[4]   Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release [J].
Andresen, TL ;
Jensen, SS ;
Jorgensen, K .
PROGRESS IN LIPID RESEARCH, 2005, 44 (01) :68-97
[5]  
Blunk T, 1996, EUR J PHARM BIOPHARM, V42, P262
[6]   The role of serum complement on the organ distribution of intravenously administered poly (methyl methacrylate) nanoparticles: Effects of pre-coating with plasma and with serum complement [J].
Borchard, G ;
Kreuter, J .
PHARMACEUTICAL RESEARCH, 1996, 13 (07) :1055-1058
[7]   Opposite β2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity [J].
Celli, CM ;
Gharavi, AE ;
Chaimovich, H .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1416 (1-2) :225-238
[8]  
CHONN A, 1992, J BIOL CHEM, V267, P18759
[9]  
Devine DV, 1997, CRIT REV THER DRUG, V14, P105
[10]   LIPOSOME-COMPLEMENT INTERACTIONS IN RAT SERUM - IMPLICATIONS FOR LIPOSOME SURVIVAL STUDIES [J].
DEVINE, DV ;
WONG, K ;
SERRANO, K ;
CHONN, A ;
CULLIS, PR .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1994, 1191 (01) :43-51